Susan Deutscher - Related publications

University of Missouri - Columbia, Columbia, MO, United States 
Biochemistry, Molecular Biology
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2020 Capasso D, Del Gatto A, Comegna D, Russo L, Fattorusso R, Saviano M, Di Gaetano S, Zaccaro L. Selective Targeting of αvβ5 Integrin in HepG2 Cell Line by RGDechi15D Peptide. Molecules (Basel, Switzerland). 25. PMID 32961684 DOI: 10.3390/molecules25184298   
2020 Meng Q, Wu Y, Sui X, Meng J, Wang T, Lin Y, Wang Z, Zhou X, Qi Y, Du J, Gao Y. POTN: A Human Leukocyte Antigen-A2 Immunogenic Peptides Screening Model and Its Applications in Tumor Antigens Prediction. Frontiers in Immunology. 11: 02193. PMID 33133063 DOI: 10.3389/fimmu.2020.02193   
2020 Wang X, Zheng Y, Bao C, Zhong G, Liu S, Wiradharma N, Fan W, Yang YY, Wang X, Huang Y. Branched α-helical peptides enhanced antitumor efficacy and selectivity. Biomaterials Science. PMID 33029595 DOI: 10.1039/d0bm00629g   
2020 Demmers LC, Kretzschmar K, Van Hoeck A, Bar-Epraïm YE, van den Toorn HWP, Koomen M, van Son G, van Gorp J, Pronk A, Smakman N, Cuppen E, Clevers H, Heck AJR, Wu W. Single-cell derived tumor organoids display diversity in HLA class I peptide presentation. Nature Communications. 11: 5338. PMID 33087703 DOI: 10.1038/s41467-020-19142-9   
2020 Dao T, Klatt MG, Korontsvit T, Mun SS, Guzman S, Mattar M, Zivanovic O, Kyi CK, Socci ND, O'Cearbhaill RE, Scheinberg DA. Impact of tumor heterogeneity and microenvironment in identifying neoantigens in a patient with ovarian cancer. Cancer Immunology, Immunotherapy : Cii. PMID 33123756 DOI: 10.1007/s00262-020-02764-9   
2020 Liu P, Tu Y, Tao J, Liu Z, Wang F, Ma Y, Li Z, Han Z, Gu Y. GRPR-targeted SPECT imaging using a novel bombesin-based peptide for colorectal cancer detection. Biomaterials Science. PMID 33140758 DOI: 10.1039/d0bm01432j   
2020 Fischer C, Munks MW, Hill AB, Kroczek RA, Bissinger S, Brand V, Schmittnaegel M, Imhof-Jung S, Hoffmann E, Herting F, Klein C, Knoetgen H. Vaccine-induced CD8 T cells are redirected with peptide-MHC class I-IgG antibody fusion proteins to eliminate tumor cells in vivo. Mabs. 12: 1834818. PMID 33151105 DOI: 10.1080/19420862.2020.1834818   
2020 Yan M, Shen M, Xu L, Huang J, He G, An M, Li X, Gao Z, Meng X. Inactivation of Pancreatic Stellate Cells by Exendin-4 Inhibits the Migration and Invasion of Pancreatic Cancer Cells. Oncotargets and Therapy. 13: 9455-9463. PMID 33061431 DOI: 10.2147/OTT.S259853   
2020 Shahsavari S, Shaghaghi Z, Abedi SM, Hosseinimehr SJ. Evaluation of Tc-HYNIC-(ser)-LTVPWY peptide for glioblastoma imaging. International Journal of Radiation Biology. 96: 502-509. PMID 31829777 DOI: 10.1080/09553002.2020.1704906   
2020 Huang C, Dai XY, Cai JX, Chen J, Wang BB, Zhu W, Wang E, Wei W, Zhang JV. A Screened GPR1 Peptide Exerts Antitumor Effects on Triple-Negative Breast Cancer. Molecular Therapy Oncolytics. 18: 602-612. PMID 33005727 DOI: 10.1016/j.omto.2020.08.013   
2020 Dehbashi M, Hojati Z, Motovali-Bashi M, Ganjalikhani-Hakemi M, Shimosaka A, Cho WC. Computational study for suppression of CD25/IL-2 interaction. Biological Chemistry. PMID 33170139 DOI: 10.1515/hsz-2020-0326   
2020 Thadi A, Gleeson EM, Khalili M, Shaikh MF, Goldstein E, Morano WF, Daniels LM, Grandhi N, Glatthorn H, Richard SD, Campbell PM, Sarafraz-Yazdi E, Pincus MR, Bowne WB. Anti-Cancer Tumor Cell Necrosis of Epithelial Ovarian Cancer Cell Lines Depends on High Expression of HDM-2 Protein in Their Membranes. Annals of Clinical and Laboratory Science. 50: 611-624. PMID 33067207   
2020 Eustace NJ, Anderson JC, Warram JM, Widden HN, Pedersen RT, Alrefai H, Patel Z, Hicks PH, Placzek WJ, Gillespie GY, Hjelmeland AB, Willey CD. A cell-penetrating MARCKS mimetic selectively triggers cytolytic death in glioblastoma. Oncogene. PMID 33077834 DOI: 10.1038/s41388-020-01511-9   
2020 von Kiedrowski V, Hübner R, Kail D, Cheng X, Schirrmacher R, Wängler C, Wängler B. Synthesis, characterization and optimization of properties of NIR-fluorescent cyclic α-MSH peptides for melanoma imaging. Journal of Materials Chemistry. B. PMID 33136101 DOI: 10.1039/d0tb01798a   
2020 Zhuang X, Maione F, Robinson J, Bentley M, Kaul B, Whitworth K, Jumbu N, Jinks E, Bystrom J, Gabriele P, Garibaldi E, Delmastro E, Nagy Z, Gilham D, Giraudo E, et al. CAR T cells targeting tumor endothelial marker CLEC14A inhibit tumor growth. Jci Insight. 5. PMID 33004686 DOI: 10.1172/jci.insight.138808   
2020 Zhuang X, Maione F, Robinson J, Bentley M, Kaul B, Whitworth K, Jumbu N, Jinks E, Bystrom J, Gabriele P, Garibaldi E, Delmastro E, Nagy Z, Gilham D, Giraudo E, et al. CAR T cells targeting tumor endothelial marker CLEC14A inhibit tumor growth. Jci Insight. 5. PMID 33004686 DOI: 10.1172/jci.insight.138808   
2020 Hedegaard CL, Redondo-Gómez C, Tan BY, Ng KW, Loessner D, Mata A. Peptide-protein coassembling matrices as a biomimetic 3D model of ovarian cancer. Science Advances. 6. PMID 33008910 DOI: 10.1126/sciadv.abb3298   
2020 Zhong T, Zhao C, Wang S, Tao D, Ma S, Shou C. The biologically functional identification of a novel TIM3-binding peptide P26 in vitro and in vivo. Cancer Chemotherapy and Pharmacology. PMID 33084973 DOI: 10.1007/s00280-020-04167-0   
2020 Sani S, Messe M, Fuchs Q, Pierrevelcin M, Laquerriere P, Entz-Werle N, Reita D, Etienne-Selloum N, Bruban V, Choulier L, Martin S, Dontenwill M. Biological relevance of RGD-integrin subtype-specific ligands in cancer. Chembiochem : a European Journal of Chemical Biology. PMID 33140906 DOI: 10.1002/cbic.202000626   
2020 Colella F, Scillitani G, Pierri CL. Sweet as honey, bitter as bile: mitochondriotoxic peptides and other therapeutic proteins isolated from animal tissues, for dealing with mitochondrial apoptosis. Toxicology. 152612. PMID 33171268 DOI: 10.1016/j.tox.2020.152612   
2020 Hasegawa T, Hayashi S, Shimizu E, Mizuno S, Niida A, Yamaguchi R, Miyano S, Nakagawa H, Imoto S. Neoantimon: a multifunctional R package for identification of tumor-specific neoantigens. Bioinformatics (Oxford, England). PMID 33123738 DOI: 10.1093/bioinformatics/btaa616   
2020 Bradley SD, Talukder AH, Lai I, Davis R, Alvarez H, Tiriac H, Zhang M, Chiu Y, Melendez B, Jackson KR, Katailiha A, Sonnemann HM, Li F, Kang Y, Qiao N, et al. Vestigial-like 1 is a shared targetable cancer-placenta antigen expressed by pancreatic and basal-like breast cancers. Nature Communications. 11: 5332. PMID 33087697 DOI: 10.1038/s41467-020-19141-w   
2020 Yasuda T, Nishiki K, Hiraki Y, Kato H, Iwama M, Shiraishi O, Yasuda A, Shinkai M, Kimura Y, Sukegawa Y, Chiba Y, Imano M, Takeda K, Satou T, Shiozaki H, et al. Phase II Adjuvant Cancer-specific Vaccine Therapy for Esophageal Cancer Patients Curatively Resected After Preoperative Therapy With Pathologically Positive Nodes; Possible Significance of Tumor Immune Microenvironment in its Clinical Effects. Annals of Surgery. PMID 33055588 DOI: 10.1097/SLA.0000000000003880   
2020 Gomez S, Tsung A, Hu Z. Current Targets and Bioconjugation Strategies in Photodynamic Diagnosis and Therapy of Cancer. Molecules (Basel, Switzerland). 25. PMID 33121022 DOI: 10.3390/molecules25214964   
2020 Hamburger AE, DiAndreth B, Cui J, Daris ME, Munguia ML, Deshmukh K, Mock JY, Asuelime GE, Lim ED, Kreke MR, Tokatlian T, Kamb A. Engineered T cells directed at tumors with defined allelic loss. Molecular Immunology. PMID 33012527 DOI: 10.1016/j.molimm.2020.09.012   
2020 Gu W, Meng F, Haag R, Zhong Z. Actively targeted nanomedicines for precision cancer therapy: Concept, construction, challenges and clinical translation. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 33022328 DOI: 10.1016/j.jconrel.2020.10.003   
2020 Luker GD, Yang J, Richmond A, Scala S, Festuccia C, Schottelius M, Wester HJ, Zimmermann J. At the bench: Pre-clinical evidence for multiple functions of CXCR4 in cancer. Journal of Leukocyte Biology. PMID 33104270 DOI: 10.1002/JLB.2BT1018-715RR   
2020 Ernst A, Hennel R, Krombach J, Kapfhammer H, Brix N, Zuchtriegel G, Uhl B, Reichel CA, Frey B, Gaipl US, Winssinger N, Shirasawa S, Sasazuki T, Sperandio M, Belka C, et al. Priming of Anti-tumor Immune Mechanisms by Radiotherapy Is Augmented by Inhibition of Heat Shock Protein 90. Frontiers in Oncology. 10: 1668. PMID 32984042 DOI: 10.3389/fonc.2020.01668   
2020 Sanchez CE, Dowlati EP, Geiger AE, Chaudhry K, Tovar MA, Bollard CM, Cruz CRY. K Cell Adoptive Immunotherapy of Cancer: Evaluating Recognition Strategies and Overcoming Limitations. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 33007496 DOI: 10.1016/j.bbmt.2020.09.030   
2020 Allen R, Ivtchenko E, Thuamsang B, Sangsuwan R, Lewis JS. Polymer-loaded hydrogels serve as depots for lactate and mimic "cold" tumor microenvironments. Biomaterials Science. PMID 33000781 DOI: 10.1039/d0bm01196g   
2020 Peng H, Wang JH, Guo F, Zhu FF, Wen ZJ, Zhong HJ, Liang DS. Legumain protease-activated tuftsin-functionalized nanoparticles for dual-targeting TAMs and cancer chemotherapy. Colloids and Surfaces. B, Biointerfaces. 197: 111442. PMID 33166937 DOI: 10.1016/j.colsurfb.2020.111442   
2020 Kitaguchi D, Oda T, Enomoto T, Ohara Y, Owada Y, Akashi Y, Furuta T, Yu Y, Kimura S, Kuroda Y, Kurimori K, Miyazaki Y, Furuya K, Shimomura O, Tateno H. Lectin Drug Conjugate Therapy for Colorectal Cancer. Cancer Science. PMID 33058342 DOI: 10.1111/cas.14687   
2020 Gan BK, Rullah K, Yong CY, Ho KL, Omar AR, Alitheen NB, Tan WS. Targeted delivery of 5-fluorouracil-1-acetic acid (5-FA) to cancer cells overexpressing epithelial growth factor receptor (EGFR) using virus-like nanoparticles. Scientific Reports. 10: 16867. PMID 33033330 DOI: 10.1038/s41598-020-73967-4   
2020 Trac N, Chen LY, Zhang A, Liao CP, Poon C, Wang J, Ando Y, Joo J, Garri C, Shen K, Kani K, Gross ME, Chung EJ. CCR2-targeted micelles for anti-cancer peptide delivery and immune stimulation. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 33011241 DOI: 10.1016/j.jconrel.2020.09.054   
2020 Haider S, Tyekucheva S, Prandi D, Fox NS, Ahn J, Xu AW, Pantazi A, Park PJ, Laird PW, Sander C, Wang W, Demichelis F, Loda M, Boutros PC, . Systematic Assessment of Tumor Purity and Its Clinical Implications. Jco Precision Oncology. 4. PMID 33015524 DOI: 10.1200/PO.20.00016   
2020 Yang X, Luo Y, Li S, Xu X, Bao Y, Yang J, Ouyang D, Fan X, Gong P, Cai L. Small Molecular Prodrug Amphiphile Self-Assembled AIE Dots for Cancer Theranostics. Frontiers in Bioengineering and Biotechnology. 8: 903. PMID 33117772 DOI: 10.3389/fbioe.2020.00903   
2020 Han J, Gao L, Wang J, Wang J. Application and development of aptamer in cancer: from clinical diagnosis to cancer therapy. Journal of Cancer. 11: 6902-6915. PMID 33123281 DOI: 10.7150/jca.49532   
2020 Pimentel VO, Yaromina A, Marcus D, Dubois LJ, Lambin P. A novel co-culture assay to assess anti-tumor CD8 T cell cytotoxicity via luminescence and multicolor flow cytometry. Journal of Immunological Methods. 112899. PMID 33068606 DOI: 10.1016/j.jim.2020.112899   
2020 Cao Y, Wang X, Jin T, Tian Y, Dai C, Widarma C, Song R, Xu F. Immune checkpoint molecules in natural killer cells as potential targets for cancer immunotherapy. Signal Transduction and Targeted Therapy. 5: 250. PMID 33122640 DOI: 10.1038/s41392-020-00348-8   
2020 Pan D, Tang Y, Tong J, Xie C, Chen J, Feng C, Hwu P, Huang W, Zhou D. An antibody-drug conjugate targeting a GSTA glycosite-signature epitope of MUC1 expressed by non-small cell lung cancer. Cancer Medicine. PMID 33084221 DOI: 10.1002/cam4.3554   
2020 Solano LN, Nelson GL, Ronayne CT, Jonnalagadda S, Jonnalagadda SK, Kottke K, Chitren R, Johnson JL, Pandey MK, Jonnalagadda SC, Mereddy VR. Synthesis, in vitro, and in vivo evaluation of novel N-phenylindazolyl diarylureas as potential anti-cancer agents. Scientific Reports. 10: 17969. PMID 33087745 DOI: 10.1038/s41598-020-74572-1   
2020 Wells DK, van Buuren MM, Dang KK, Hubbard-Lucey VM, Sheehan KCF, Campbell KM, Lamb A, Ward JP, Sidney J, Blazquez AB, Rech AJ, Zaretsky JM, Comin-Anduix B, Ng AHC, Chour W, ... , et al. Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction. Cell. PMID 33038342 DOI: 10.1016/j.cell.2020.09.015   
2020 Su CY, Li JQ, Zhang LL, Wang H, Wang FH, Tao YW, Wang YQ, Guo QR, Li JJ, Liu Y, Yan YY, Zhang JY. The Biological Functions and Clinical Applications of Integrins in Cancers. Frontiers in Pharmacology. 11: 579068. PMID 33041823 DOI: 10.3389/fphar.2020.579068   
2020 Balhorn R, Balhorn MC. Therapeutic applications of the selective high affinity ligand drug SH7139 extend beyond non-Hodgkin's lymphoma to many other types of solid cancers. Oncotarget. 11: 3315-3349. PMID 32934776 DOI: 10.18632/oncotarget.27709   
2020 Wang Q, Zhan Y, Ling S, Huang H, Zhang Y, Chen G, Huang S, Li C, Guo W. Rapid and Nondestructive Histopathological Analysis for Intraoperative Cancer Diagnosis Using an Enzyme-Activated NIR-II Nanoprobe. Angewandte Chemie (International Ed. in English). PMID 33015947 DOI: 10.1002/anie.202011903   
2020 Qu J, Mei Q, Chen L, Zhou J. Chimeric antigen receptor (CAR)-T-cell therapy in non-small-cell lung cancer (NSCLC): current status and future perspectives. Cancer Immunology, Immunotherapy : Cii. PMID 33025047 DOI: 10.1007/s00262-020-02735-0   
2020 Alzamely KO, Hajizadeh F, Heydari M, Ghaderi Sede MJ, Asl SH, Peydaveisi M, Masjedi A, Izadi S, Nikkhoo A, Atyabi F, Namdar A, Baradaran B, Sojoodi M, Jadidi-Niaragh F. Combined inhibition of CD73 and ZEB1 by Arg-Gly-Asp (RGD)-targeted nanoparticles inhibits tumor growth. Colloids and Surfaces. B, Biointerfaces. 197: 111421. PMID 33130525 DOI: 10.1016/j.colsurfb.2020.111421   
2020 Perez RE, Calhoun S, Shim D, Levenson VV, Duan L, Maki CG. Prolyl endopeptidase inhibitor Y-29794 blocks the IRS1-AKT-mTORC1 pathway and inhibits survival and tumor growth of triple-negative breast cancer. Cancer Biology & Therapy. 1-8. PMID 33044914 DOI: 10.1080/15384047.2020.1824989   
2020 Caruso FP, Garofano L, D'Angelo F, Yu K, Tang F, Yuan J, Zhang J, Cerulo L, Pagnotta SM, Bedognetti D, Sims PA, Suvà M, Su XD, Lasorella A, Iavarone A, et al. A map of tumor-host interactions in glioma at single-cell resolution. Gigascience. 9. PMID 33155039 DOI: 10.1093/gigascience/giaa109   
2020 Biteghe FAN, Mungra N, Chalomie NET, Ndong JC, Engohang-Ndong J, Vignaux G, Padayachee E, Naran K, Barth S. Advances in epidermal growth factor receptor specific immunotherapy: lessons to be learned from armed antibodies. Oncotarget. 11: 3531-3557. PMID 33014289 DOI: 10.18632/oncotarget.27730